In summary, our findings indicated that the DDX21-induced ac4C modification axis is an important regulator of CRC metastasis and angiogenesis; hence, blocking the DDX21/NAT10 axis is a promising strategy for CRC treatment. The gene discussed is DDX21; the disease is colorectal carcinoma.